Outcome and response to neoadjuvant chemotherapy in patients with advanced stage Müllerian cancer in <em>BRCA1/2</em> mutation-positive compared to mutation-negative women

Mahdi, Haider

210 - Poster Session A
Outcome and response to neoadjuvant chemotherapy in patients with advanced stage Müllerian cancer in BRCA1/2 mutation-positive compared to mutation-negative women

Saturday, March 22, 2014: 9:05 AM

West Exhibit Hall (Tampa Convention Center)

H. Mahdi¹, J. R. Woessner², M. E. Buechel², J. Moline², C. Eng², C. Michener¹ and P. G. Rose¹
¹Cleveland Clinic, Cleveland, OH, ²The Cleveland Clinic, Cleveland, OH

45th Annual Meeting on Women's Cancer

March 21 - 25, 2014

Navigation

210 - Poster Session A
Outcome and response to neoadjuvant chemotherapy in patients with advanced stage Müllerian cancer in BRCA1/2 mutation-positive compared to mutation-negative women

210 - Poster Session A Outcome and response to neoadjuvant chemotherapy in patients with advanced stage Müllerian cancer in BRCA1/2 mutation-positive compared to mutation-negative women

210 - Poster Session A
Outcome and response to neoadjuvant chemotherapy in patients with advanced stage Müllerian cancer in BRCA1/2 mutation-positive compared to mutation-negative women